{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T16:06:32Z","timestamp":1774973192520,"version":"3.50.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2016,3,11]],"date-time":"2016-03-11T00:00:00Z","timestamp":1457654400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,3,11]],"date-time":"2016-03-11T00:00:00Z","timestamp":1457654400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bundesgesundheitsbl."],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1007\/s00103-016-2317-8","type":"journal-article","created":{"date-parts":[[2016,3,11]],"date-time":"2016-03-11T09:04:46Z","timestamp":1457687086000},"page":"465-474","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Kompetenznetz Darmerkrankungen","Inflammatory Bowel Disease Competence Network"],"prefix":"10.1007","volume":"59","author":[{"given":"Stefan","family":"Schreiber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heinz","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"Kruis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Torsten","family":"Kucharzik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonas","family":"Mudter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Britta","family":"Siegmund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Stallmach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Witte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus","family":"Fitzke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernd","family":"Bokemeyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,3,11]]},"reference":[{"issue":"Suppl 1","key":"2317_CR1","first-page":"A220","volume":"2","author":"B Bokemeyer","year":"2014","unstructured":"Bokemeyer B, Helwig U, Teich N et al (2014) TNF-alpha as induction and maintenance therapy for Crohn\u2019s disease. United European Gastroenterol J 2(Suppl 1):A220\u2013P0328","journal-title":"United European Gastroenterol J"},{"issue":"Suppl 1","key":"2317_CR2","first-page":"359","volume":"9","author":"B Bokemeyer","year":"2015","unstructured":"Bokemeyer B, Langbrandter J, Jessen P et al (2015) P559 Improving health care of patients with inflammatory bowel diseases (IBD) by Fostering Networking of Physicians \u2013 it\u2019s not that easy! J Crohns Colitis 9(Suppl 1):359\u2013360","journal-title":"J Crohns Colitis"},{"key":"2317_CR3","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/ng.553","volume":"42","author":"A Franke","year":"2010","unstructured":"Franke A, Balschun T, Sina C et al (2010) Genome-wide association study for ulcerative colitis identifies risk loci at 7q22 and 22q13 (IL17REL). Nat Genet 42:292\u2013294","journal-title":"Nat Genet"},{"key":"2317_CR4","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/j.crohns.2014.02.026","volume":"8","author":"S Ghosh","year":"2014","unstructured":"Ghosh S, Pariente B, Mould D et al (2014) New tools and approaches for improved management of inflammatory bowel diseases. J Crohns Colitis 8:1246\u20131253","journal-title":"J Crohns Colitis"},{"issue":"7408","key":"2317_CR5","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/nature11228","volume":"487","author":"T Hashimoto","year":"2012","unstructured":"Hashimoto T, Perlot T, Rehman A et al (2012) ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation. Nature 487(7408):477\u2013481","journal-title":"Nature"},{"issue":"7","key":"2317_CR6","first-page":"1041","volume":"109","author":"M Karner","year":"2014","unstructured":"Karner M, Kocjan A, Stein J et al (2014) First multicenter study of modified release phosphatidylcholine \u201cLT-02\u201d in ulcerative colitis: a randomized, placebo-controlled trial in mesalazine-refractory courses. J Gastroenterol 109(7):1041\u20131051","journal-title":"J Gastroenterol"},{"key":"2317_CR7","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1055\/s-0031-1275829","volume":"136","author":"German IBD Study Group","year":"2011","unstructured":"German IBD Study Group (2011) Adherence to the H1N1 vaccination recommendation in patients with Crohn\u2019s disease or ulcerative colitis. Dtsch Med Wochenschr 136:939\u2013943","journal-title":"Dtsch Med Wochenschr"},{"issue":"15","key":"2317_CR8","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1056\/NEJM199710093371502","volume":"337","author":"SR Targan","year":"1997","unstructured":"Targan SR, Hanauer SB, van Deventer SJ et al (1997) A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn\u2019s disease. Crohn\u2019s Disease cA2 Study Group. N Engl J Med 337(15):1029\u20131035","journal-title":"N Engl J Med"},{"key":"2317_CR9","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1055\/s-0028-1109323","volume":"47","author":"H Raspe","year":"2009","unstructured":"Raspe H, Conrad S, Muche-Borowski C (2009) Evidenzbasierte und interdisziplin\u00e4r konsentierte Versorgungspfade f\u00fcr Patientinnen und Patienten mit Morbus Crohn oder Colitis ulcerosa. Z\u00a0Gastroenterol 47:541\u2013562","journal-title":"Z Gastroenterol"},{"key":"2317_CR10","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1056\/NEJMoa067594","volume":"357","author":"WJ Sandborn","year":"2007","unstructured":"Sandborn WJ, Feagan BG, Stoinov S et al (2007) Precise 1 Study Investigators. Certolizumab pegol for the treatment of Crohn\u2019s disease. N Engl J Med 357:228\u2013238","journal-title":"N Engl J Med"},{"key":"2317_CR11","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1056\/NEJMoa1203572","volume":"367","author":"WJ Sandborn","year":"2012","unstructured":"Sandborn WJ, Gasink C, Gao LL et al (2012) Certifi Study Group. Ustekinumab induction and maintenance therapy in refractory Crohn\u2019s disease. N Engl J Med 367:1519\u20131528","journal-title":"N Engl J Med"},{"key":"2317_CR12","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1111\/apt.12930","volume":"40","author":"WJ Sanborn","year":"2014","unstructured":"Sanborn WJ, Lee SD, Randall C et al (2014) Long-term safety and efficacy of certolizumab pegol in the treatment of Crohn\u2019s disease: 7\u2011year results from the precise 3 study. Aliment Pharmacol Ther 40:903\u2013916","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"2317_CR13","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1055\/s-0034-1399400","volume":"53","author":"S Schreiber","year":"2015","unstructured":"Schreiber S, Dignass AU, Hartmann H et al (2015) Current position on Vedolizimab for ulcerative colitis and Crohn\u2019s disease. Z Gastroenterol 53(6):591\u2013602","journal-title":"Z Gastroenterol"},{"key":"2317_CR14","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1056\/NEJMoa062897","volume":"357","author":"S Schreiber","year":"2007","unstructured":"Schreiber S, Khaliq-Kareemi M, Lawrance I et al (2007) Precise 2 Study Investigators. Maintenance therapy with certolizumab pegol for Crohn\u2019s disease. N Engl J Med 357:239\u2013250","journal-title":"N Engl J Med"},{"issue":"47","key":"2317_CR15","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1055\/s-0034-1387371","volume":"139","author":"S Schreiber","year":"2014","unstructured":"Schreiber S, Luger T, Mittendorf T et al (2014) Evolution of biologicals in inflammation medicine \u2013 biosimilars in gastroenterology, rheumatology and dermatology. Dtsch Med Wochenschr 139(47):2399\u20132404","journal-title":"Dtsch Med Wochenschr"}],"container-title":["Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00103-016-2317-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00103-016-2317-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00103-016-2317-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00103-016-2317-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T01:27:18Z","timestamp":1593653238000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00103-016-2317-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,11]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["2317"],"URL":"https:\/\/doi.org\/10.1007\/s00103-016-2317-8","relation":{},"ISSN":["1436-9990","1437-1588"],"issn-type":[{"value":"1436-9990","type":"print"},{"value":"1437-1588","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,11]]},"assertion":[{"value":"11 March 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Das Projekt wurde \u00fcber 10\u00a0Jahre vom BMBF gef\u00f6rdert. Zahlreiche Vorstandsmitglieder des Kompetenznetzes Darmerkrankungen erhielten in den letzten Jahren verschiedene DFG\/EU-F\u00f6rderungen. Einladungen zu Vortr\u00e4gen oder Einzelberatungen wurden in diesem Zusammenhang nicht als \u201eInteressenkonflikt\u201c aufgefasst.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine von den Autoren durchgef\u00fchrten Studien an Menschen oder Tieren.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}